Last reviewed · How we verify
NCT06670586
Assessment of Reproductive Outcomes in Non-Male Factor Infertility Patients: Conventional in Vitro Fertilisation Versus Intracytoplasmic Sperm Injection
NA trial testing conventional in vitro fertilization in In Vitro Fertilization in 128 participants. Participants enrolled and being followed up; not accepting new ones.
30 November 2023
Quick facts
| Lead sponsor | Maria Dolores Cuquerella Fernandez-Vazquez |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 128 |
| Start date | 1 January 2022 |
| Primary completion | 30 November 2023 |
| Estimated completion | 1 March 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- conventional in vitro fertilization
- intracytoplasmic sperm injection (ICSI) — full drug profile →
Conditions studied
- In Vitro Fertilization — all drugs for In Vitro Fertilization →
- Infertility Assisted Reproductive Technology — all drugs for Infertility Assisted Reproductive Technology →
Sponsor
Maria Dolores Cuquerella Fernandez-Vazquez
Who can join
Adults 18 to 40, female only, with In Vitro Fertilization or Infertility Assisted Reproductive Technology. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this clinical trial is to evaluate the efficiency of two fertilization techniques used in Assisted Reproduction: conventional In Vitro fertilization (cIVF) and Intracytoplasmic Sperm Injection (ICSI), in terms of in-vitro and clinical results, in non-male infertility patients, comparing them in sibling oocytes. The main questions it aims to answer are: Does ICSI result in better fertilization rate, blastocyst rate or usable blastocyst rate? Does ICSI result in better pregnancy, clinical pregnancy and live birth rates? Researchers will compare cIVF to ICSI in sibling oocytes to assess if a technique offers better results. Participants undergoing an IVF/ICSI cycle will have their oocytes randomly divided in two groups: the oocytes from one group will be fertilized using cIVF and the oocytes from the other group using ICSI.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06670586
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for In Vitro Fertilization
Currently open trials in the same condition.
- NCT07500337 — Day-4 Embryo Defragmentation: Blastocyst Rate and clInical Outcomes · NA · recruiting
- NCT06766604 — Effect of Super-GDF9 on CAPA-IVM of COCs From Small Antral Follicles · NA · recruiting
- NCT06261671 — Effect of Antioxydant-enriched Media on Blastocyst Euploidy Rates. · NA · recruiting
- NCT06521957 — Effectiveness of CBT in Improving Psycho-Neuro-Endocrine Factors in Women Following In Vitro Fertilization Program · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06670586 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Maria Dolores Cuquerella Fernandez-Vazquez
- Last refreshed: 14 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06670586.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing